Salah Beck, DO
Obstetrics & Gynecology · Decatur, ALNPI 1497142103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations.
Across 142 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$440
- Mayne Pharma Commercial LLC$369
- Pfizer$315
- Shield Therapeutics Inc$178
- Sage Therapeutics, LLC$169
- Channel Medsystems, Inc.$161
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,48994%
- Education$1566%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 23 | $440 |
| Mayne Pharma Commercial LLC | 31 | $369 |
| Pfizer | 17 | $315 |
| Shield Therapeutics Inc | 9 | $178 |
| Sage Therapeutics, LLC | 10 | $169 |
| Channel Medsystems, Inc. | 2 | $161 |
| AbbVie | 9 | $155 |
| Exeltis, USA Inc. | 7 | $132 |
| Conmed Corporation | 2 | $94 |
| Axonics, Inc. | 4 | $71 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Aspira Women's Health Inc | 1 | $61 |
| Daiichi Sankyo Inc. | 3 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Exact Sciences | 2 | $38 |
| Merck | 2 | $38 |
| Bayer | 2 | $36 |
| Boston Scientific | 1 | $32 |
| Hologic Sales And Service, LLC | 2 | $25 |
| Organon | 1 | $24 |
| Millicent US Inc | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $18 |
| Monaghan Medical Corporation | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $15 |
| Urovant Sciences Inc | 1 | $13 |
How this compares
$2,645 in reported general payments places this provider in the 70th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 11 | $979 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Decatur
- Mitchell SchusterDecatur$7K
- Theodore TsaltasBirmingham$853K
- Richard BrownGulf Shores$429K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Praful PatelDothan$65K
- Angela McCool-PearsonFairhope$57K
- Tomeka RobertsBirmingham$44K
- Percy HudsonBirmingham$29K
- Heidi StraughnBirmingham$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.